Michael Alfieri
Head of Finance and Principal Financial & Accounting OfficerMr. Michael Alfieri, also known as Mike, is Principal Financial & Accounting Officer of Aldeyra Therapeutics, Inc. from August 31, 2024 and serves as its Head of Finance. He served as Principal Financial Officer and Principal Accounting Officer at Genocea Biosciences, Inc. since June 21, 2018 until March 5, 2019. He served as Vice President of Finance at Genocea Biosciences, Inc. since May 2018. Mr. Alfieri has served as a consultant with Danforth, a provider of strategic and operational finance and accounting for life science companies, since September 2019, where he provides financial consulting services to both public and private pharma and biotechnology companies. Prior to then, Mr. Alfieri served as Vice President, Finance of Radius Health, Inc., a biopharmaceutical company, from January 2017 through April 2018. Prior to Radius, Mr. Alfieri served as Corporate Controller of Merrimack Pharmaceuticals, Inc., a biopharmaceutical company from 2014 to 2017. Mr. Alfieri holds both a B.S. and a M.S. from Bentley University.
Positions
- Company NameAldeyra Therapeutics, Inc.Stock CodeALDXPositionHead of Finance and Principal Financial & Accounting OfficerColleagues
- TCTodd C. BradyCEO, President & Director
- RHRichard Huntington DouglasIndependent Chair of the Board
- DBDavid BurkeHead of Investor Relations
- ALAdam LazorchakDirector of Translational Sciences & Non-Clinical Development
- GMGary M. PhillipsIndependent Director
- BRBen R. BronsteinIndependent Director
- DMDarlene M. Deptula-HicksIndependent Director
